IGC Pharma Inc (IGC)
NYSEAMERICAN: IGC · IEX Real-Time Price · USD
0.460
-0.021 (-4.37%)
At close: Jul 19, 2024, 4:00 PM
0.461
+0.001 (0.20%)
Pre-market: Jul 22, 2024, 4:06 AM EDT
IGC Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IGC Pharma stock have an average target of 3.38, with a low estimate of 3.25 and a high estimate of 3.50. The average target predicts an increase of 634.78% from the current stock price of 0.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IGC Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 |
|---|---|
| Strong Buy | 2 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +660.87% | Jul 17, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $3.25 | Strong Buy | Reiterates | $3.25 | +606.52% | Jun 21, 2024 |
Financial Forecast
Revenue This Year
1.41M
from 1.35M
Increased by 5.06%
Revenue Next Year
n/a
from 1.41M
EPS This Year
-0.16
from -0.22
EPS Next Year
n/a
from -0.16
Revenue Forecast
| Revenue | 2024 |
|---|---|
| High | 1.5M |
| Avg | 1.4M |
| Low | 1.4M |
Revenue Growth
| Revenue Growth | 2024 |
|---|---|
| High | 9.2% |
| Avg | 5.1% |
| Low | 1.9% |
EPS Forecast
| EPS | 2024 |
|---|---|
| High | -0.17 |
| Avg | -0.16 |
| Low | -0.16 |
EPS Growth
| EPS Growth | 2024 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.